Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Other Operating Expenses (2018 - 2025)

AVITA Medical (RCEL) has disclosed Other Operating Expenses for 7 consecutive years, with $11.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses fell 15.39% year-over-year to $11.9 million, compared with a TTM value of $53.1 million through Dec 2025, down 8.69%, and an annual FY2025 reading of $53.1 million, down 8.69% over the prior year.
  • Other Operating Expenses was $11.9 million for Q4 2025 at AVITA Medical, down from $12.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $16.3 million in Q2 2024 and bottomed at $59000.0 in Q4 2023.
  • Average Other Operating Expenses over 4 years is $7.7 million, with a median of $11.9 million recorded in 2025.
  • The sharpest move saw Other Operating Expenses plummeted 94.25% in 2023, then surged 23813.56% in 2024.
  • Year by year, Other Operating Expenses stood at $1.0 million in 2022, then tumbled by 94.25% to $59000.0 in 2023, then soared by 23813.56% to $14.1 million in 2024, then fell by 15.39% to $11.9 million in 2025.
  • Business Quant data shows Other Operating Expenses for RCEL at $11.9 million in Q4 2025, $12.1 million in Q3 2025, and $14.3 million in Q2 2025.